← Back to catalogue

Sickledex

FDA UDI

Class II (US FDA UDI)

by Streck

Identity

Trade Name
SICKLEDEX FDA UDI
Generic Name
Haemoglobin S (HbS) IVD, control FDA UDI
Device Name
A qualitative solubility test kit used to detect the presence of sickling hemoglobins in human blood or sickle cell control material. Contains 100 tests. FDA UDI
Model / Reference
217657 FDA UDI
Description
A qualitative solubility test kit used to detect the presence of sickling hemoglobins in human blood or sickle cell control material. Contains 100 tests. FDA UDI

Identifiers

Catalog Number
217657 FDA UDI
Primary DI / UDI-DI
00844509002048 FDA UDI
510(k) Number
K023656 FDA UDI
FDA Product Code
GHM FDA UDI
GMDN Term
Haemoglobin S (HbS) IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7825 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Haemoglobin S (HbS) IVD, control

Sickledex by Streck — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Haemoglobin S (HbS) IVD, control.

Cleared under the same submission

K023656 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Streck

Sources (1)

  • FDA UDI 8b5f3956-2b9e-492c-8ad2-59684b109768 37 fields · synced May 30, 2026